Down 57%, Is AbCellera Biologics a Buy on the Dip? [Yahoo! Finance]
We're Not Very Worried About AbCellera Biologics' (NASDAQ:ABCL) Cash Burn Rate [Yahoo! Finance]
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcare Conference on June 10, 2024
Earnings Release: Here's Why Analysts Cut Their AbCellera Biologics Inc. (NASDAQ:ABCL) Price Target To US$12.71 [Yahoo! Finance]
AbCellera Biologics Inc. (NASDAQ: ABCL) had its price target lowered by analysts at KeyCorp from $8.00 to $7.00. They now have an "overweight" rating on the stock.